Abdelmeguid NE, Hammad TM, Abdel-Moneim AM, Salam SA (2022) Effect of Epigallocatechin-3-gallate on Stress-Induced depression in a mouse model: role of Interleukin-1β and Brain-Derived neurotrophic factor. Neurochem Res 47:3464–3475. https://doi.org/10.1007/s11064-022-03707-9
Article PubMed PubMed Central CAS Google Scholar
Ai N, Wood RD, Welsh WJ (2015) Identification of Nitazoxanide as a group I metabotropic glutamate receptor negative modulator for the treatment of neuropathic pain: an in Silico drug repositioning study. Pharm Res. https://doi.org/10.1007/s11095-015-1665-7
Amireddy N, Puttapaka SN, Vinnakota RL et al (2017) The unintended mitochondrial uncoupling effects of the FDA-approved anti-helminth drug Nitazoxanide mitigates experimental parkinsonism in mice. J Biol Chem 292:15731–15743. https://doi.org/10.1074/jbc.M117.791863
Article PubMed PubMed Central CAS Google Scholar
Brunier A, MM (2016) Investing in treatment for depression and anxiety leads to fourfold return. World Health Organization
Cantley LC (2002) The phosphoinositide 3-Kinase pathway. Sci (1979) 296:1655–1657. https://doi.org/10.1126/science.296.5573.1655
Carlén M (2017) What constitutes the prefrontal cortex? Sci (1979) 358:478–482. https://doi.org/10.1126/science.aan8868
Charan J, Kantharia ND (2013) How to calculate sample size in animal studies? J Pharmacol Pharmacother 4:303–306. https://doi.org/10.4103/0976-500X.119726
Article PubMed PubMed Central Google Scholar
de Azevedo W Jr, Dias R (2008) Computational methods for calculation of Ligand-Binding affinity. Curr Drug Targets 9:1031–1039. https://doi.org/10.2174/138945008786949405
Deng Z, Yuan C, Yang J et al (2019) Behavioral defects induced by chronic social defeat stress are protected by momordica Charantia polysaccharides via Attenuation of JNK3/PI3K/AKT neuroinflammatory pathway. Ann Transl Med 7:6–6. https://doi.org/10.21037/atm.2018.12.08
Article PubMed PubMed Central CAS Google Scholar
El-Kowrany SI, El Ghaffar AE-SA, Shoheib ZS et al (2019) Evaluation of Nitazoxanide as a novel drug for the treatment of acute and chronic toxoplasmosis. Acta Trop 195:145–154. https://doi.org/10.1016/j.actatropica.2019.04.013
Article PubMed CAS Google Scholar
Emamian ES, Hall D, Birnbaum MJ et al (2004) Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia. Nat Genet 36:131–137. https://doi.org/10.1038/ng1296
Article PubMed CAS Google Scholar
Fan L, Qiu X, Zhu Z et al (2019) Nitazoxanide, an anti-parasitic drug, efficiently ameliorates learning and memory impairments in AD model mice. Acta Pharmacol Sin 40:1279–1291. https://doi.org/10.1038/s41401-019-0220-1
Article PubMed PubMed Central CAS Google Scholar
Gautam K, Singh P (2024) Tapestry of Mental Illnesses: Exploring Causes, Symptoms and Mechanisms Behind the Veil of Depression. In: Contemporary Research and Perspectives in Biological Science 5(BP International):37–71
Goodsell DS, Zardecki C, Di Costanzo L et al (2020) RCSB protein data bank: enabling biomedical research and drug discovery. Protein Sci 29:52–65. https://doi.org/10.1002/pro.3730
Article PubMed CAS Google Scholar
Guo P, Fang Y, Feng M et al (2022) Study on the changes in circadian rhythm before and after treatment and the influencing factors in patients with depression. Neuropsychiatr Dis Treat Volume 18:2661–2669. https://doi.org/10.2147/NDT.S384879
Guo N, Wang X, Xu M et al (2024) PI3K/AKT signaling pathway: molecular mechanisms and therapeutic potential in depression. Pharmacol Res 206:107300. https://doi.org/10.1016/j.phrs.2024.107300
Article PubMed CAS Google Scholar
Han C, Pei H, Shen H et al (2023) Antcin K targets NLRP3 to suppress neuroinflammation and improve the neurological behaviors of mice with depression. Int Immunopharmacol 117:109908. https://doi.org/10.1016/j.intimp.2023.109908
Article PubMed CAS Google Scholar
Hassamal S (2023) Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories. Front Psychiatry 14. https://doi.org/10.3389/fpsyt.2023.1130989
Hooft RWW, Sander C, Vriend G Positioning hydrogen atoms by optimizing hydrogen-bond networks in protein structures. Proteins:, Structure (1996) Function, and Genetics 26:363–376. https://doi.org/10.1002/(SICI)1097-0134(199612)26:4%3C;363::AID-PROT1%3E;3.0.CO;2-D
Hosseinzadeh Kasani P, Lee JE, Park C et al (2023) Evaluation of nutritional status and clinical depression classification using an explainable machine learning method. Front Nutr 10. https://doi.org/10.3389/fnut.2023.1165854
Huang D, Wang L, Wu Y et al (2022) Metabolomics based on peripheral blood mononuclear cells to dissect the mechanisms of Chaigui granules for treating depression. ACS Omega 7:8466–8482. https://doi.org/10.1021/acsomega.1c06046
Article PubMed PubMed Central CAS Google Scholar
Iob E, Kirschbaum C, Steptoe A (2020) Persistent depressive symptoms, HPA-axis hyperactivity, and inflammation: the role of cognitive-affective and somatic symptoms. Mol Psychiatry 25:1130–1140. https://doi.org/10.1038/s41380-019-0501-6
Jejurikar BL, RSH (2021) Drug designing in discovery studio. Asian J Res Chem 14:135–138
Kessler RC, Amminger GP, Aguilar-Gaxiola S et al (2007) Age of onset of mental disorders: a review of recent literature. Curr Opin Psychiatry 20:359–364. https://doi.org/10.1097/YCO.0b013e32816ebc8c
Article PubMed PubMed Central Google Scholar
Kiehl IGA, Riccetto E, Salustiano ACC et al (2021) Boosting bladder cancer treatment by intravesical Nitazoxanide and Bacillus calmette-guérin association. World J Urol 39:1187–1194. https://doi.org/10.1007/s00345-020-03294-w
Article PubMed CAS Google Scholar
Křenek P, Hořínková J, Bartečků E (2023) Peripheral inflammatory markers in subtypes and core features of depression: A systematized review. Psychopathology 56:403–416. https://doi.org/10.1159/000528907
Kulkarni VS, Alagarsamy V, Solomon VR et al (2023) Drug repurposing: an effective tool in modern drug discovery. Russ J Bioorg Chem 49:157–166. https://doi.org/10.1134/S1068162023020139
Article PubMed PubMed Central CAS Google Scholar
Kumar V, Doshi G (2025) Investigating the antidepressant effects of amantadine combined with amitriptyline in a chronic unpredictable mild stress model in mice. Neurosci Lett 851:138169. https://doi.org/10.1016/j.neulet.2025.138169
Article PubMed CAS Google Scholar
Li C, Wang F, Han Y et al (2024) Nitazoxanide reduces inflammation and bone erosion in mice with collagen-induced arthritis via inhibiting the JAK2/STAT3 and NF-κB pathways in fibroblast-like synoviocytes. Biomed Pharmacother 171:116195. https://doi.org/10.1016/j.biopha.2024.116195
Article PubMed CAS Google Scholar
Lipina TV, Fletcher PJ, Lee FH et al (2013) Disrupted-In-Schizophrenia-1 Gln31Leu polymorphism results in social anhedonia associated with monoaminergic imbalance and reduction of CREB and β-arrestin-1,2 in the nucleus accumbens in a mouse model of depression. Neuropsychopharmacology 38:423–436. https://doi.org/10.1038/npp.2012.197
Article PubMed CAS Google Scholar
Liu Q, Zhang J, Xiao C et al (2022) Akebia saponin D protects hippocampal neurogenesis from microglia-mediated inflammation and ameliorates depressive-like behaviors and cognitive impairment in mice through the PI3K-Akt pathway. Front Pharmacol 13. https://doi.org/10.3389/fphar.2022.927419
Lucido MJ, Dunlop BW (2025) Emerging medications for Treatment-Resistant depression: A review with perspective on mechanisms and challenges. Brain Sci 15:161. https://doi.org/10.3390/brainsci15020161
Article PubMed PubMed Central CAS Google Scholar
Miricescu D, Totan A, Stanescu-Spinu I-I et al (2020) PI3K/AKT/mTOR signaling pathway in breast cancer: from molecular landscape to clinical aspects. Int J Mol Sci 22:173. https://doi.org/10.3390/ijms22010173
Article PubMed PubMed Central CAS Google Scholar
Nascimento C, Nunes PV, Suemoto CK et al (2020) Differential levels of inflammatory and neuroendocrine markers in the hippocampus and anterior cingulate cortex of bipolar disorder subjects: A post-mortem study. Brain Behav Immun 90:286–293.
Comments (0)